Search for: "Amneal Pharmaceuticals LLC" Results 1 - 20 of 48
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jul 2020, 10:53 am by Matthew L.M. Fletcher
Amneal Pharmaceuticals, LLC (Opioid Manufacturing) U.S. [read post]
15 Jul 2020, 1:56 pm by Unknown
Amneal Pharmaceuticals, LLC (Opioid Manufacturing) U.S. [read post]
14 Jul 2020, 5:00 am by Carolyn Casey, J.D.
The makers named in the recall are Apotex Corp., Amneal Pharmaceuticals, Marksans Pharma Limited’s Time-Cap Labs, Inc., Lupin Pharmaceuticals Inc., and Teva Pharmaceuticals USA, Inc. [read post]
16 Jun 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC) and its related limiting doctrines, prosecution history estoppel (Amgen Inc. v. [read post]
11 May 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC") is most frequently rebutted by the doctrine of prosecution history estoppel ("Pharma Tech Solutions, Inc. v. [read post]
15 Apr 2020, 7:54 am by Dennis Crouch
Amneal Pharmaceuticals LLC. [read post]
14 Oct 2019, 10:36 am by Renae Lloyd
As of last Tuesday, the biggest losers, included energy, healthcare and communications companies, according to Bloomberg: Amneal Pharmaceuticals LLC (AMRX CUSIP: 03168L105)  – $2.7 billion loan due 2025 has sunk to about 80 cents on the dollar, Seadrill Operating LP (SDRL CUSIP: G7998G106) – $2.6 billion loan maturing in 2021 fetches around 53 cents. [read post]
9 Oct 2018, 5:00 am by Anjelica Cappellino
Amneal Pharm., LLC, 2013 WL 1932927 at *9 (D.N.J. 2013) or it contains “substantial new data and information” exceeding the original report. [read post]
12 Sep 2018, 9:46 am by Eric Caligiuri
This case was originally filed in March 2016 by Galderma against Amneal Pharmaceuticals under the HatchWaxman Act, 35 U.S.C. [read post]
5 Sep 2018, 10:44 am by Jay W. Belle Isle
The ruling, following a four-day trial in Delaware federal court, is a victory for Robins Kaplan’s client, Amneal Pharmaceuticals LLC. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
7 Dec 2017, 9:34 pm by Patent Docs
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
20 Apr 2017, 9:58 pm by Patent Docs
., Amneal Pharmaceuticals LLC, Amneal... [read post]